Under TEAM and CJR-X, hospitals carry risk for outcomes that occur after discharge, often in independent practices, and see results months after each year closes. The Circles Platform records the whole episode at the point of care, every entry traceable, with outcome measures available as patients report them.
TEAM began in 2026; CJR-X goes nationwide in January 2028. The hip and knee outcome measure needs a survey within 90 days before surgery and another 300 to 425 days after. CMS reconciles after year end; Circles captures both surveys and reports progress during the year.
Complications, readmissions and patient-reported outcomes recorded across the whole episode, including the surgeon’s office, therapy and home health, and visible as they occur. OIG found that a quarter of Medicare inpatients experienced harm; events after discharge rarely reach the hospital’s record.
Standards of care built from the system’s own measured outcomes, shared by employed and independent clinicians on one protocol, and shown to payers, employers and patients with data each can trace to its source.
Circles Datasets created by the hospital’s clinicians can be licensed to device makers, sponsors, payers and AI developers, with most of the value allocated to the Circle Members. Rural hospitals can fund Circles through Rural Health Transformation Program awards.
A vendor sells a hospital a tool and leaves the hospital to find the return.
The Circles model ties RegenMed’s return to the value of the evidence the hospital’s clinicians create.
EHRs record the hospital’s own encounters; claims record what was billed; registries record what was abstracted. None follows the patient after discharge, and none can later show that a value came from an identified clinician, answered a defined question and was linked to the outcome months or years later.
Circles Datasets can, because the Circles Platform is a closed system in which every entry is attributed and time-stamped against a protocol question. Payers, regulators, device makers and AI developers increasingly require this evidence, and a hospital’s existing systems were not built to produce it.
Prospective outcome data exists only where clinicians and patients keep answering. inCytes™ asks each clinician only the questions their role requires, and returns comparative reports, Circle Hours and co-authored publications.
Patients see their own recovery in Benchmarc™. MOTIV™ reports 87% clinician and 93% patient completion.
A brokered dataset transfers its liability to the buyer, because a licensee cannot show what any patient agreed to. The Circles Platform is built the other way: consent terms travel with the data and provenance is recorded at entry.
Allocation to clinicians follows only the volume and completeness of their data, never a product, prescription or referral. Local data nodes, now in pilot, will keep records inside the hospital.
Hospitals host the encounters from which outcome evidence is made, yet the value of that evidence leaves with the data.
Circles Datasets turn those encounters into licensable evidence for device makers, drug sponsors, payers, public programs and AI developers.
One academic hospital spent 108,478 person-hours and over $5 million in staff time reporting 162 quality metrics in a year.
When measures are built into a protocol, reporting becomes a query on a live system rather than chart abstraction.
A protocol built on the CMS hip and knee outcome measure captures the pre-operative and one-year surveys from surgeons’ offices and patients, with complications and post-acute care across the episode. The hospital sees its measure as it accumulates, not after reconciliation.
Neither. A registry abstracts what was documented; a Circle records the episode its protocol defines, including outcomes after discharge, for every enrolled patient. The EMR remains the record of care; Circles runs alongside it and requires no replacement.
Licensed datasets are de-identified under HIPAA, as the hospital’s business associate agreement authorizes, and licenses bar re-identification. Verified conclusions, now in pilot, will let a buyer confirm a result without receiving any record. Consent terms stay attached to each patient’s data.
The Circle Members who create it, under the Circles Dataset Ownership Agreement. A hospital can be a member, or sponsor a Circle and hold the members’ share. Typically 85% of license value goes to members; RegenMed retains a minimum of 15%.
Agreement on the protocol, often an existing one such as MOTIV™, and clinicians willing to enroll every eligible patient. No hardware, no local installation and no added staff are required.